
Ceptradin-S 500mg/250mg Injection
Marketer
Taj Pharma India Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Ceptradin-S 500mg/250mg Injection
Combiflox 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and spread. Administration must be strictly under medical guidance; complete the prescribed regimen, even with symptom improvement, to ensure full efficacy. Premature cessation may compromise treatment effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; escalate symptoms warrant immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require prompt emergency care. Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased somnolence. While generally non-impairing to driving ability, refrain from operating vehicles if experiencing drowsiness or dizziness. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your doctor might order blood tests and other diagnostics to monitor treatment response.
Primary Ingredients of Ceptradin-S 500mg/250mg Injection
No text provided to rephrase.
Uses of Ceptradin-S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Ceptradin-S 500mg/250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ceptradin-S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceptradin-S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Ceptradin-S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Ceptradin-S 500mg/250mg Injection, offer a powerful antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to survive. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Ceptradin-S 500mg/250mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceptradin-S (500mg/250mg) is typically deemed safe for use in pregnant individuals. Preclinical trials using animal models have revealed minimal or no negative impacts on fetal development; nonetheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
The administration of Ceptradin-S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Ceptradin-S 500mg/250mg Injection can lead to reduced alertness, visual impairment, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ceptradin-S 500mg/250mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The injectable formulation of Ceptradin-S (500mg/250mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Ceptradin-S (500mg/250mg) injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ceptradin-S 500mg/250mg Injection :
Should you inadvertently omit a scheduled dose of Ceptradin-S 500mg/250mg Injection, seek medical advice.
Facts to Know About Ceptradin-S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
